QIP-ADMET
Overview
QIP-ADMET is an AI solution developed by Standigm that provides rapid and reliable predictions of Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) for drug candidates. This accelerates the drug discovery process by guiding the selection of viable drug candidates through the assessment of their pharmacokinetic and toxicological profiles.
The QIP-ADMET model utilizes a graph transformer architecture, pretrained on extensive datasets that include quantum mechanical properties. It employs a multi-task learning framework to simultaneously predict multiple ADMET properties, which enhances the robustness and accuracy of its predictions. The model has demonstrated superior predictive accuracy compared to existing commercial and published models, covering 43 ADMET-related endpoints. QIP-ADMET also offers an interpretability module that provides visual insights into molecular structures, highlighting regions favorable or unfavorable for a predicted property.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-powered ADMET prediction
- Quantum-informed pretraining
- Graph transformer architecture
- Multi-task learning framework
- 43 ADMET-related endpoints covered
- Predictive accuracy surpassing commercial products
- Interpretability module with visual insights
- Supports post-training adaptation to user-provided data
- Efficient binding affinity prediction (within M4 framework)
- Molecular encoder embedded within M4 framework
Use Cases
- Accelerating drug discovery
- Guiding selection of viable drug candidates
- Assessing pharmacokinetic profiles of drug candidates
- Evaluating toxicological profiles of drug candidates
- Optimizing hit-to-lead and lead optimization processes
- Virtual screening campaigns
What Physicians Need to Know
QIP-ADMET is a powerful tool for researchers and pharmaceutical scientists in the early stages of drug discovery, enabling rapid and accurate prediction of a compound's ADMET profile. While not directly applicable for clinical patient care, understanding the ADMET properties of potential drug candidates is crucial for developing safer and more effective medications that will eventually reach patients. Physicians involved in clinical research or drug development can leverage insights from tools like QIP-ADMET to better understand the pharmacological characteristics of investigational drugs and anticipate potential challenges in clinical trials. It helps in making data-driven decisions to select promising drug candidates, thereby minimizing costly setbacks in later development phases.
QIP-ADMET is offered as an AI SaaS and API solution, suggesting it can be integrated into existing drug discovery workflows and platforms. The availability of its models and source code on GitHub implies flexibility for developers to incorporate its predictive capabilities into custom environments, particularly those built with Python. The M4 framework, which powers QIP-ADMET, is designed for modularity and can incorporate proprietary data for post-training adaptation, allowing for tailored predictions. Standigm welcomes collaborations to customize M4 components to partners' unique data assets and therapeutic areas.
Details
| Category | Developer Tools & APIs, Drug Discovery & Research, Pharmacology & Dosing AI |
| Pricing | Unknown — unknown |
| Deployment | Cloud-based (SaaS) |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
Not applicable AI-estimated QIP-ADMET is an AI-powered prediction tool for drug discovery and is not a medical device that requires FDA clearance. It is used in the early stages of drug development to assess candidate properties, not for direct patient diagnosis or treatment. |
| Integrations | |
| EHR | Not specified |
| Specialties | Hematology, Infectious Disease, Oncology |
What the Web Says
QIP-ADMET by Standigm is an AI-powered platform designed to accelerate drug discovery by providing swift and reliable predictions of Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) properties. It leverages advanced molecular representation learning, pretraining on quantum chemistry datasets, and a graph transformer architecture to achieve superior predictive accuracy compared to existing models. The platform also offers an interpretability module for visual insights into molecular structures.
Overall: PositiveStrengths
- Superior predictive accuracy across multiple ADMET tasks, outperforming existing commercial and published models.
- Leverages advanced molecular representation learning and pretraining on quantum chemistry datasets.
- Employs a graph transformer architecture for robust and generalizable representations.
- Provides an interpretability module with clear visual insights into molecular structures, highlighting favorable and unfavorable regions.
- Supports post-training adaptation to user-provided data, allowing incorporation of proprietary experimental results.
- Offers swift and reliable predictions, accelerating drug discovery efforts.
Limitations
- General ADMET prediction models, including AI-based ones, can be limited by the quality and size of training datasets, especially for novel chemical spaces or larger compounds.
- The validity of reported ADMET model performance remains a concern, with potential issues like overfitting, data leakage, and inadequate validation.
- Some Reddit discussions suggest that ADMET predictions are primarily used for triage, with experiments still being the ultimate reliance for mature chemical matter.
- There is a general lack of high-quality, comprehensive ADMET data, which can hinder the progress of predictive toxicology.
- The complexity of ADMET properties means that predictions, while insightful, may not always achieve high accuracy and should be combined with other approaches.
- No specific negative reviews for QIP-ADMET were found from physicians, healthcare IT, tech reviewers, G2, or Capterra in the search results.
Based on reviews from: Standigm, ACS Publications, Reddit, PubMed, ResearchGate, YouTube
Last updated: 2026-08-06
Ratings & Reviews
Rate QIP-ADMET
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for QIP-ADMET.
